Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome

BACKGROUND: Forkhead box (FOXP3) is considered to be a specific marker for regulatory T cells. The aim of this study was to correlate intragraft FOXP3 at mRNA and cellular levels during renal allograft rejection to response to therapy and late clinical outcome.

METHODS: Immunostainings and quantitative reverse-transcriptase polymerase chain reaction for FOXP3, CD3, and transforming growth factor (TGF)-beta were performed and results were related to histopathologic and clinical outcome.

RESULTS: A good correlation between immunohistochemical analysis and mRNA levels for both CD3 and FOXP3 was observed. Intragraft FOXP3 was significantly related to tubulitis and interstitial fibrosis. A strong correlation was found between FOXP3 and CD3 mRNA and between FOXP3 and TGF-beta mRNA. No correlation was found between FOXP3 and response to therapy.

DISCUSSION: In conclusion, intragraft FOXP3 at both cellular and molecular levels parallels T-cell infiltration during acute rejection. FOXP3 does not predict response to antirejection therapy. FOXP3 correlates with renal fibrosis, TGF-beta, and poor late renal outcome.

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:87

Enthalten in:

Transplantation - 87(2009), 9 vom: 15. Mai, Seite 1377-80

Sprache:

Englisch

Beteiligte Personen:

Yapici, Unsal [VerfasserIn]
Bemelman, Fréderike J [VerfasserIn]
Scheepstra, Cornelis G [VerfasserIn]
Roelofs, Joris J T H [VerfasserIn]
Claessen, Nike [VerfasserIn]
van der Loos, Chris [VerfasserIn]
van Donselaar-van der Pant, Karlijn [VerfasserIn]
Bouts, Antonia H M [VerfasserIn]
Idu, Mirza M [VerfasserIn]
Rowshani, Ajda T [VerfasserIn]
ten Berge, Ineke J M [VerfasserIn]
Florquin, Sandrine [VerfasserIn]

Links:

Volltext

Themen:

Antigens, CD
CD3 Complex
FOXP3 protein, human
Forkhead Transcription Factors
Journal Article
RNA, Messenger
Research Support, Non-U.S. Gov't
Transforming Growth Factor beta

Anmerkungen:

Date Completed 08.07.2009

Date Revised 16.11.2017

published: Print

Citation Status MEDLINE

doi:

10.1097/TP.0b013e3181a24a4b

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM188355170